News > Regulatory

07th October 2019

Medilink UK and Mediwales to give Wales MedTech businesses detailed guidance on how to prepare for Brexit

Medilink UK, a membership organisation representing over 1350 medical technology and life-science companies, and Mediwales, are hosting a free event on 8thOctober in Cardiff at the Village Hotel (29 Pendwyallt Road, Cardiff, CF14 7EF) to help life science businesses prepare for Brexit. There are over 13,000 life science jobs in Wales and over 1800 in…

26th August 2019

UK Supreme Court approves ‘Skinny Labelling’

The UK’s highest court has held that patents directed towards new medical uses for known products must disclose some sound scientific reasoning or directly relevant experimental evidence in support of the claimed use.  The test for infringement of such patents is likely to depend primarily on the objective appearance and presentation of an allegedly infringing…

19th August 2019

Webinar Follow Up – Regulation of Medical and IVD Devices in relation to EU Exit

Further to the webinar facilitated last week, MHRA have confirmed they are happy for us to share the slides and all relevant links/follow up e-mail to all out MDCC suppliers and trade associations. The Webinar was held on Friday 19th July covering an Update Regulation of Medical Devices and In-Vitro Diagnostic Devices. Please find attached the…

01st July 2019

New legislation introduced to provide further quality in Welsh health and social care

A new Bill which aims to improve quality and public engagement in health and social care will officially be introduced to the National Assembly for Wales by Health and Social Services Minister Vaughan Gething today. The Health and Social Care (Quality and Engagement) (Wales) Bill will embed a system-wide approach to quality in health for…

29th April 2019

Sharp receives MHRA approval for Clinical Services Centre of Excellence

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received approval from the Medicines and Healthcare Product Regulatory Agency (MHRA) to begin production at its Clinical Services Centre of Excellence in Rhymney, UK. Following a successful inspection by the MHRA, Sharp can now offer a range of…

12th March 2019

Brexit and the effect on the UK medical device industry – How one company has dealt with the challenge

For a long time the restless elephant in the room, Brexit has now turned into an angry bull, still locked down but ready to erupt and no matter which side of this now existential divide you stand on, this bull, once released will liberate vast amounts of pent up energy. For Brexiteers (supporters of Brexit)…

26th February 2019

Welsh SME Manufacturing Sector Remains Confident About Future Growth

Wales-based companies in the manufacturing and engineering sectors remain confident about future growth, despite continuing uncertainty surrounding Brexit, rising production costs and skill shortages, according to a new survey. The latest Manufacturing and Engineering Report by UK professional advisory and accountancy network MHA, found that not only are 84% of SME manufacturers in Wales predicting…

19th February 2019

ABPI Publish Report on Bridging the Skills Gap in the Biopharmaceutical Industry

ABPI release report following 2018 survey on the skills gap in the biopharmaceutical industry. The Association of the British Pharmaceutical Industry has published a report on the skills gaps within the pharmaceutical industry, titled ‘Bridging the Skills Gap in the Biopharmaceutical Industry: Maintaining the UK’s Leading Position in Life Sciences’. The report looks at the…

30th January 2019

Into 2019: Intelligent Innovation’s Role In The Shape Of Medtech Things To Come

Executive Summary Brexit, the “Implant Files” and the new EU regulations – however large they loom at present, they will in time be seen as mere tactical challenges for a global medtech industry working hard to ensure that it is ready for the massive health-care delivery and service-oriented changes to come. Preparing for the future…

07th January 2019

£1.3 billion industry/government investment in UK economy and new partnership driving early disease detection

The second Life Sciences Sector Deal will support healthcare innovation and back businesses to create high-paid, high-quality jobs. life-saving early disease detection technology to be developed by new partnership between government and industry using artificial intelligence (AI) to develop the next generation of treatments, including a first-of-its-kind national health programme the second Life Sciences Sector…